Pseudopterosin A-D Modulates Dendritic Cell Activation in Skin Sensitization.

Area of Science:

• Marine natural products
• Immunology
• Dermatology

Background:

• Nickel sulfate (NiSO4) is a common cause of allergic contact dermatitis.
• Current treatments like corticosteroids have limitations.
• Marine diterpene glycosides, such as pseudopterosin A-D (PsA-D), are being explored for their therapeutic potential.

Purpose of the Study:

• To investigate the anti-inflammatory effects of PsA-D on NiSO4-induced skin sensitization.
• To evaluate PsA-D's efficacy in preclinical models of skin sensitization.
• To compare PsA-D's effectiveness with dexamethasone.

Main Methods:

• Utilized dermal dendritic cell (DDC) surrogates to assess NiSO4-induced activation markers (CD54, CD86) and NF-κB pathway.
• Measured pro-inflammatory cytokine secretion (IL-8, IL-6, IL-1β) in response to NiSO4 and PsA-D.
• Employed a full-thickness human skin model to evaluate topical PsA-D's effect on NiSO4-induced mRNA expression of inflammatory mediators (IL-8, IL-6, IL-1β, COX-2, NLRP3).

Main Results:

• PsA-D pre-treatment significantly reduced NiSO4-induced CD54 and CD86 upregulation in DDC surrogates.
• PsA-D inhibited NiSO4-induced NF-κB activation by preventing IκBα degradation.
• PsA-D suppressed the secretion of IL-8, IL-6, and IL-1β, and attenuated mRNA expression of these cytokines and mediators (COX-2, NLRP3) in human skin models.
• PsA-D demonstrated comparable efficacy to dexamethasone.

Conclusions:

• PsA-D exhibits significant anti-inflammatory effects against NiSO4-induced skin sensitization.
• PsA-D acts by modulating key inflammatory pathways and cytokine production.
• PsA-D represents a promising therapeutic alternative to corticosteroids for allergic contact dermatitis, warranting further research into formulation and bioavailability.